Fighting Melanoma,
With combination immunotherapy, the 5-year survival of patients with advanced melanoma is now approximately 50%. Outcomes can…
With combination immunotherapy, the 5-year survival of patients with advanced melanoma is now approximately 50%. Outcomes can…
In a new editorial, Phillip Scheinberg, M.D., Ph.D., reports on an important advance in the medical management of severe…